Top Page
Challenger
(Sydney:CGF)
Challenger (CGF) vs. iShares MSCI Australia ETF (EWA)
Challenger Business Overview & Revenue Model
Challenger Financial Statement Overview
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.58B | 3.28B | 2.23B | -414.30M | 3.03B | 1.51B |
| Gross Profit | 2.90B | 635.90M | 652.20M | 1.36B | 1.79B | 1.38B |
| EBITDA | 1.04B | 924.70M | 780.70M | 348.20M | 1.14B | -390.80M |
| Net Income | 146.00M | 129.90M | 287.50M | 253.70M | 592.30M | -416.00M |
Balance Sheet | ||||||
| Total Assets | 33.87B | 33.41B | 30.98B | 29.74B | 29.99B | 28.57B |
| Cash, Cash Equivalents and Short-Term Investments | 556.70M | 573.20M | 593.40M | 733.10M | 989.40M | 661.90M |
| Total Debt | 1.68B | 7.13B | 5.89B | 5.85B | 6.39B | 7.81B |
| Total Liabilities | 30.02B | 29.52B | 26.81B | 25.75B | 26.17B | 25.33B |
| Stockholders Equity | 3.85B | 3.88B | 4.16B | 3.99B | 3.83B | 3.25B |
Cash Flow | ||||||
| Free Cash Flow | 341.00M | 841.80M | 1.27B | 2.48B | 2.56B | 475.60M |
| Operating Cash Flow | 342.00M | 843.70M | 1.27B | 2.49B | 2.58B | 484.90M |
| Investing Cash Flow | -643.40M | -1.94B | -1.34B | -2.12B | -865.00M | -1.48B |
| Financing Cash Flow | 270.10M | 1.08B | -35.00M | -619.80M | -1.38B | 863.30M |
Challenger Technical Analysis
Challenger Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | AU$1.73B | 26.54 | 4.09% | ― | 31.62% | -22.24% | |
70 Outperform | AU$129.92M | 9.11 | 17.27% | ― | 82.25% | 73.36% | |
67 Neutral | $16.66B | 11.44 | 9.71% | 3.92% | 11.61% | -10.70% | |
67 Neutral | AU$4.31B | 29.51 | 20.18% | 3.29% | 36.76% | 70.74% | |
66 Neutral | AU$8.04B | 78.81 | 65.17% | 1.07% | 24.24% | 33.94% | |
61 Neutral | $5.52B | 37.69 | 3.85% | 3.62% | 17.95% | -34.24% | |
57 Neutral | €2.08B | ― | -24.47% | 6.70% | 5.36% | -846.00% |
Challenger Corporate Events
Challenger Limited has announced a change in its substantial holding in Lynas Rare Earths Ltd, with a slight increase in its voting power from 5.08% to 6.12%. This adjustment in stakeholding reflects Challenger’s strategic interest in Lynas Rare Earths, potentially impacting its investment portfolio and market positioning.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a change in its substantial holding in Close The Loop Limited. This adjustment in shareholding reflects a strategic move by Challenger to manage its investment portfolio, potentially impacting its influence in Close The Loop and signaling a shift in its market strategy.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Apollo Global Management, Inc. and its affiliates have ceased to be substantial holders in Challenger Limited as of June 19, 2025. This change follows the sale of 35,187,082 fully paid ordinary shares in Challenger Limited by AP Liberty GP, LLC and Apollo Management Holdings, marking a significant shift in the company’s shareholder structure.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Goldman Sachs Australia Pty Ltd has entered into an agreement to underwrite a secondary block of Ordinary Shares in Challenger Limited, resulting in a temporary relevant interest of approximately 5.54% of Challenger’s Ordinary Shares. This interest will cease following the settlement scheduled for June 19, 2025, as per the terms of the Sale Agreement, indicating a strategic financial maneuver by Goldman Sachs that could impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
TAL Dai-ichi Life Australia Pty Ltd has entered into a conditional agreement to acquire 33,234,618 fully paid ordinary shares in Challenger Limited from AP Liberty GP, LLC. This acquisition represents a significant change in the substantial holdings of Challenger Limited, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
TAL Dai-ichi Life Australia Pty Ltd has entered into a conditional agreement to acquire 33,234,618 fully paid ordinary shares in Challenger Limited from AP Liberty GP, LLC. This acquisition increases TAL’s voting power in Challenger to 19.90%, potentially enhancing its influence and strategic positioning within the company.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the appointment of David Whittle as a director, effective June 17, 2025. The initial director’s interest notice indicates that Whittle currently holds no relevant interests in securities, which may suggest a focus on governance and oversight rather than direct financial involvement. This appointment could potentially impact the company’s strategic direction and governance structure, aligning with its ongoing efforts to strengthen leadership and enhance stakeholder confidence.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the appointment of John Somerville as a director, effective June 17, 2025. The initial director’s interest notice reveals that Somerville currently holds no relevant interests in securities as a registered holder or through contracts, indicating a fresh start in his role at the company.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has become a substantial holder with a significant voting power in the company, as indicated by the recent acquisition of various securities. This development highlights Challenger’s strategic move to strengthen its influence and control within the market, potentially impacting its operations and positioning in the industry.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in Monash IVF Group Limited. This change reflects a shift in Challenger’s investment strategy, potentially impacting its portfolio and market positioning. The announcement may have implications for stakeholders, including adjustments in voting rights and investment focus.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has expressed support for APRA’s consultation on capital settings for annuity products, which aims to create a more market-sensitive framework with appropriate risk controls. This regulatory reform is expected to foster innovation, enhance the uptake of lifetime income products, and offer retirees more choice and certainty. The proposed changes are seen as a significant improvement, aligning asset and liability cashflows and reducing required capital levels, thereby improving the financial resilience of life insurers and promoting the growth of the annuity market.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced that it has ceased to be a substantial holder in a company or scheme as of June 10, 2025. This change reflects adjustments in the relevant interests and associations of the substantial holder, which may impact the company’s voting securities and influence within the market. The announcement could have implications for stakeholders as it signifies a shift in the company’s investment strategy or portfolio management.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a change in its substantial holding status, as State Street Corporation and its subsidiaries have ceased to be substantial holders as of June 4, 2025. This change in substantial holding status may impact the company’s shareholder structure and influence its future voting dynamics.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$6.60 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a change in its substantial holding in Smartgroup Corporation Ltd, increasing its voting power from 5.04% to 6.07%. This adjustment in holdings reflects Challenger’s strategic positioning and potential influence within Smartgroup, which could have implications for stakeholders and the market perception of both companies.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.20 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a significant development in its shareholder structure, with State Street Global Advisors Europe Limited becoming a substantial holder. This change in voting power and relevant interests may impact the company’s governance and strategic decisions, potentially influencing its market positioning and stakeholder relationships.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a new distribution for its security, CAP NOTE 3-BBSW+3.60% PERP NON-CUM RED T-05-29, with a distribution amount of AUD 1.28. The ex-date is set for August 14, 2025, with the record date on August 15, 2025, and payment scheduled for August 25, 2025. This discretionary distribution is contingent upon the absence of any payment conditions on the relevant date, highlighting the company’s ongoing commitment to providing returns to its investors.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited announced a new distribution for its Capital Notes 3, with a payment amount of AUD 1.45, scheduled for August 25, 2025. This discretionary distribution, subject to certain conditions, reflects the company’s ongoing commitment to providing returns to its stakeholders, potentially enhancing its market position in the financial services sector.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited’s Managing Director and CEO, Nick Hamilton, is set to present at the Bell Potter Emerging Leaders Conference in Sydney. This presentation underscores Challenger’s commitment to enhancing its market presence and highlights its role in providing financial security for retirees, potentially impacting its operational strategies and stakeholder engagement.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced the appointment of John Somerville and David Whittle as independent Non-Executive Directors, effective from June 2025, while JoAnne Stephenson will retire. These appointments reflect Challenger’s commitment to board renewal and enhancing its strategic capabilities, particularly in governance, risk management, and digital innovation. The changes are expected to support the company’s growth and digital transformation strategy, strengthening its position in the retirement and income market.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a change in its substantial holding in Cleanaway Waste Management Limited. The notice indicates a shift in the voting power of Challenger Limited, reflecting its strategic adjustments in investment holdings, which may impact its market positioning and influence within the industry.
The most recent analyst rating on (AU:CGF) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Challenger stock, see the AU:CGF Stock Forecast page.
Challenger Limited has announced a change in its substantial holding in Breville Group Ltd, increasing its voting power from 5.99% to 7.41%. This change reflects Challenger’s strategic adjustments in its investment portfolio, potentially impacting its influence in Breville Group and signaling its ongoing commitment to optimizing its investment strategies.
Challenger Limited has announced that State Street Corporation and its subsidiaries have become substantial holders in the company, gaining significant voting power through various securities. This development indicates a strategic positioning by State Street Corporation, potentially impacting Challenger Limited’s governance and influencing its market strategies.
Challenger Limited has announced a change in the interests of its director, Nicolas Hamilton, involving an off-market trade of 15,150 ordinary shares. This adjustment reflects a shift in the distribution of shares between Hamilton’s direct holdings and those held by NALT Superannuation Pty Ltd, with potential implications for the company’s governance and shareholder structure.
Challenger Limited has announced a revision to its 2025 financial calendar, specifically changing the date for the 2025 Investor Day and scheduling the 2026 first quarter update for October 16, 2025. This adjustment in the financial calendar is crucial for stakeholders to align their expectations and plans with the company’s updated timeline, ensuring transparency and efficient communication with investors.
Challenger Limited has announced a change in its substantial holding in Imricor Medical Systems, Inc., increasing its voting power from 6.26% to 7.27%. This adjustment in holdings reflects Challenger’s strategic investment decisions, potentially impacting its influence within Imricor and indicating a strengthened position in the market.
Challenger Limited has announced a change in its substantial holding in IRESS Limited, indicating an adjustment in its voting power from 8.23% to 7.20%. This change reflects Challenger’s ongoing management of its investment portfolio and may impact its influence within IRESS Limited, potentially affecting stakeholders’ interests and market perceptions.
Challenger Limited has announced a change in the director’s interest notice, indicating that Director Lisa Gray has increased her indirect interest in the company by acquiring 8,333 ordinary shares through an on-market trade. This acquisition raises her total holdings to 16,436 shares, reflecting a continued confidence in the company’s prospects. Such changes in director holdings can signal potential strategic shifts or confidence in the company’s future performance, which may be of interest to investors and stakeholders.
Challenger Limited has announced a change in its substantial holding in Amplitude Energy Limited, increasing its voting power from 7.66% to 9.09%. This change reflects a strategic move by Challenger to strengthen its influence and investment in Amplitude Energy, potentially impacting the company’s market positioning and stakeholder interests.
TAL Dai-ichi Life, a subsidiary of Dai-ichi Life Holdings, has acquired a 15.1% minority stake in Challenger Limited from MS&AD Insurance Group Holdings at a premium price. This strategic investment is expected to strengthen Challenger’s growth strategy and provide financial confidence to more Australians in retirement. The existing reinsurance partnership with MS Primary will remain unaffected, ensuring continued collaboration and value creation. The acquisition is subject to regulatory approvals, and MS&AD’s representative will step down from Challenger’s board following the sale.
Challenger Limited, a company listed on the Australian Securities Exchange (ASX) under the symbol CGF, is involved in a significant transaction as TAL Dai-ichi Life Australia Pty Ltd (TAL) has entered into a conditional agreement to acquire shares held by Citicorp Nominees Pty Limited on behalf of MS&AD Insurance Group Holdings, Inc. This acquisition marks a substantial change in shareholding, as indicated by the Notice of Initial Substantial Holder filed under the Corporations Act 2001. The transaction could have implications for Challenger Limited’s market position and stakeholder dynamics.
Challenger Limited has announced a change in substantial holdings, as State Street Corporation and its subsidiaries have ceased to be substantial holders as of March 31, 2025. This change in holdings may impact the company’s voting securities and could influence its market dynamics and stakeholder relationships.
Challenger Limited has issued a notice regarding its voting shares and derivative exposures. The company currently holds 2,009,509 ordinary shares, representing 0.2906% of the total shares in Challenger. The notice details changes in share interests and derivative exposures since the previous notice, including acquisitions and forfeitures of shares by the Challenger Performance Plan Trust. This update is part of the company’s compliance with the Corporations Act 2001.
Challenger Limited announced the resignation of Mr. Hiroyuki Iioka as an Alternate Director to Mr. Masahiko Kobayashi, effective March 31, 2025, following his retirement from MS&AD Insurance Group Holdings Inc. This change in the board of directors may have implications for the company’s governance and strategic direction, potentially affecting stakeholders’ interests.